Laurent Kaiser
Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study
Mombelli M, Manuel O, Hirsch H, Van Delden C, Mueller N, Koller M, Pascual M, Hirzel C, Kaiser L, Soccal P, Egli A, Boggian K, Christoph B, Benden C, Aubert J, Neofytos D, Lang B, Swiss Transplant Cohort Study. Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study. Am J Transplant 2020
31.10.2020Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study
31.10.2020Am J Transplant 2020
Mombelli Matteo, Manuel Oriol, Hirsch Hans H, Van Delden Christian, Mueller Nicolas J, Koller Michael, Pascual Manuel, Hirzel Cédric, Kaiser Laurent, Soccal Paola M, Egli Adrian, Boggian Katia, Christoph Berger, Benden Christian, Aubert John-David, Neofytos Dionysios, Lang Brian M, Swiss Transplant Cohort Study
Influenza-associated aspergillosis in critically-ill patients-a retrospective bicentric cohort study
Waldeck F, Kleger G, Pugin J, Maggiorini M, Boggian K, Schrenzel J, Kaiser L, Iten A, Notter J, Flury D, Wendel Garcia P, Suh N, Boroli F, Albrich W. Influenza-associated aspergillosis in critically-ill patients-a retrospective bicentric cohort study. Eur J Clin Microbiol Infect Dis 2020; 39:1915-1923.
03.06.2020Influenza-associated aspergillosis in critically-ill patients-a retrospective bicentric cohort study
03.06.2020Eur J Clin Microbiol Infect Dis 2020; 39:1915-1923
Waldeck Frederike, Kleger Gian-Reto, Pugin Jérôme, Maggiorini Marco, Boggian Katia, Schrenzel Jacques, Kaiser Laurent, Iten Anne, Notter Julia, Flury Domenica, Wendel Garcia Pedro David, Suh Noémie, Boroli Filippo, Albrich Werner
Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial
von Dach E, Bochud P, Kaiser L, Harbarth S, Rossel A, McCallin S, Lemmenmeier E, Kohler P, Huttner B, Gayet-Ageron A, Flury D, Cuvelier C, Prendki V, Brunel A, Albrich W, Huttner A. Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial. JAMA 2020; 323:2160-2169.
02.06.2020Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial
02.06.2020JAMA 2020; 323:2160-2169
von Dach Elodie, Bochud Pierre-Yves, Kaiser Laurent, Harbarth Stephan, Rossel Anne, McCallin Shawna, Lemmenmeier Eva, Kohler Philipp, Huttner Benedikt, Gayet-Ageron Angèle, Flury Domenica, Cuvelier Clémence, Prendki Virginie, Brunel Anne-Sophie, Albrich Werner, Huttner Angela
IFNL3/4 polymorphisms are associated with AIDS-related Kaposi's sarcoma
Bibert S, Bochud P, Cavassini M, Fellay J, Osthoff M, Kaiser L, Hoffmann M, Günthard H, Furrer H, Bernasconi E, Tarr P, Taffé P, Wójtowicz A, and the Swiss HIV Cohort Study. IFNL3/4 polymorphisms are associated with AIDS-related Kaposi's sarcoma. AIDS 2018
17.09.2018IFNL3/4 polymorphisms are associated with AIDS-related Kaposi's sarcoma
17.09.2018AIDS 2018
Bibert Stéphanie, Bochud Pierre-Yves, Cavassini Matthias, Fellay Jacques, Osthoff Michael, Kaiser Laurent, Hoffmann Matthias, Günthard Huldrych F, Furrer Hansjakob, Bernasconi Enos, Tarr Philip E, Taffé Patrick, Wójtowicz Agnieszka, and the Swiss HIV Cohort Study
PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia
Huttner A, Albrich W, Bochud P, Gayet-Ageron A, Rossel A, Dach E, Harbarth S, Kaiser L. PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia. BMJ Open 2017; 7:e017996.
13.07.2017PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia
13.07.2017BMJ Open 2017; 7:e017996
Huttner Angela, Albrich Werner, Bochud Pierre-Yves, Gayet-Ageron Angèle, Rossel Anne, Dach Elodie von, Harbarth Stephan, Kaiser Laurent
Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Terczyńska-Dyla E, Moradpour D, Mullhaupt B, Negro F, Santoro R, Semela D, Semmo N, Swiss Hepatitis C Cohort Study Group, Heim M, Bochud P, Mangia A, Malinverni R, Bibert S, Duong F, Krol I, Jørgensen S, Collinet E, Kutalik Z, Aubert V, Cerny A, Kaiser L, Hartmann R. Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes. Nat Commun 2015; 6:7280.
29.06.2015Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
29.06.2015Nat Commun 2015; 6:7280
Terczyńska-Dyla Ewa, Moradpour Darius, Mullhaupt Beat, Negro Francesco, Santoro Rosanna, Semela David, Semmo Nasser, Swiss Hepatitis C Cohort Study Group, Heim Markus H, Bochud Pierre-Yves, Mangia Alessandra, Malinverni Raffaele, Bibert Stéphanie, Duong Francois H T, Krol Ilona, Jørgensen Sanne, Collinet Emilie, Kutalik Zoltán, Aubert Vincent, Cerny Andreas, Kaiser Laurent, Hartmann Rune
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Terczyńska-Dyla E, Moradpour D, Mullhaupt B, Negro F, Santoro R, Semela D, Semmo N, Swiss Hepatitis C Cohort Study Group, Heim M, Bochud P, Mangia A, Malinverni R, Bibert S, Duong F, Krol I, Jørgensen S, Collinet E, Kutalik Z, Aubert V, Cerny A, Kaiser L, Hartmann R. Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes. Nat Commun 2014; 5:5699.
23.12.2014Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
23.12.2014Nat Commun 2014; 5:5699
Terczyńska-Dyla Ewa, Moradpour Darius, Mullhaupt Beat, Negro Francesco, Santoro Rosanna, Semela David, Semmo Nasser, Swiss Hepatitis C Cohort Study Group, Heim Markus H, Bochud Pierre-Yves, Mangia Alessandra, Malinverni Raffaele, Bibert Stéphanie, Duong Francois H T, Krol Ilona, Jørgensen Sanne, Collinet Emilie, Kutalik Zoltán, Aubert Vincent, Cerny Andreas, Kaiser Laurent, Hartmann Rune
The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients
Bibert S, Bochud P, Cavassini M, Osthoff M, Kaiser L, Hoffmann M, Günthard H, Furrer H, Bernasconi E, Manuel O, Taffé P, Wójtowicz A. The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients. AIDS 2014; 28:1885-9.
24.08.2014The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients
24.08.2014AIDS 2014; 28:1885-9
Bibert Stéphanie, Bochud Pierre-Yves, Cavassini Matthias, Osthoff Michael, Kaiser Laurent, Hoffmann Matthias, Günthard Huldrych F, Furrer Hansjakob, Bernasconi Enos, Manuel Oriol, Taffé Patrick, Wójtowicz Agnieszka
Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma
Lange C, Bochud P, Kutalik Z, Moradpour D, Semela D, Negro F, Mullhaupt B, Malinverni R, Kaiser L, Heim M, Cerny A, Cellerai C, Dufour J, Bibert S, Swiss Hepatitis C Cohort Study Group. Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma. J Hepatol 2013; 59:504-9.
09.05.2013Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma
09.05.2013J Hepatol 2013; 59:504-9
Lange Christian M, Bochud Pierre-Yves, Kutalik Zoltán, Moradpour Darius, Semela David, Negro Francesco, Mullhaupt Beat, Malinverni Raffaele, Kaiser Laurent, Heim Markus H, Cerny Andreas, Cellerai Cristina, Dufour Jean-François, Bibert Stéphanie, Swiss Hepatitis C Cohort Study Group
Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland
Kenfak-Foguena A, Cavassini M, Izpopet J, Abravanel F, Moradpour D, Jost J, Gurter-De La Fuente V, Elzi L, Evison J, Kaiser L, Kovari H, Darling K, Witteck A, Bürgisser P, Schöni-Affolter F, Data Center of the Swiss HIV Cohort Study, Lausanne, Switzerland. Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland. Emerging Infect Dis 2011; 17:1074-8.
01.06.2011Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland
01.06.2011Emerging Infect Dis 2011; 17:1074-8
Kenfak-Foguena Alain, Cavassini Matthais, Izpopet Jacques, Abravanel Florence, Moradpour Darius, Jost Josef, Gurter-De La Fuente Vanina, Elzi Luigia, Evison John-Marc, Kaiser Laurent, Kovari Helen, Darling Katharine E A, Witteck Andrea, Bürgisser Phillippe, Schöni-Affolter Franziska, Data Center of the Swiss HIV Cohort Study, Lausanne, Switzerland
Infrequent transmission of HIV-1 drug-resistant variants
Yerly S, Perrin L, Hirschel B, Perneger T, Bernard M, Gebhardt M, Rickenbach M, Bürgisser P, Chanzy B, Furrer H, Battegay M, Vernazza P, Chave J, Kaiser L, Flepp M, Telenti A, Jost S, Swiss HIV Cohort Study. Infrequent transmission of HIV-1 drug-resistant variants. Antiviral therapy 2004; 9:375-84.
01.06.2004Infrequent transmission of HIV-1 drug-resistant variants
01.06.2004Antiviral therapy 2004; 9:375-84
Yerly Sabine, Perrin Luc, Hirschel Bernard, Perneger Thomas, Bernard Marie-Charlotte, Gebhardt Martin, Rickenbach Martin, Bürgisser Philippe, Chanzy Bruno, Furrer Hansjakob, Battegay Manuel, Vernazza Pietro, Chave Jean-Philippe, Kaiser Laurent, Flepp Markus, Telenti Amalio, Jost Stéphanie, Swiss HIV Cohort Study
Monitoring of cytomegalovirus infection in solid-organ transplant recipients by an ultrasensitive plasma PCR assay
Hadaya K, Wunderli W, Deffernez C, Martin P, Mentha G, Binet F, Perrin L, Kaiser L. Monitoring of cytomegalovirus infection in solid-organ transplant recipients by an ultrasensitive plasma PCR assay. Journal of clinical microbiology 2003; 41:3757-64.
01.08.2003Monitoring of cytomegalovirus infection in solid-organ transplant recipients by an ultrasensitive plasma PCR assay
01.08.2003Journal of clinical microbiology 2003; 41:3757-64
Hadaya Karine, Wunderli Werner, Deffernez Christelle, Martin Pierre-Yves, Mentha Gilles, Binet Françoise-Isabelle, Perrin Luc, Kaiser Laurent